Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3390/molecules26103003

http://scihub22266oqcxt.onion/10.3390/molecules26103003
suck pdf from google scholar
34070140!8158358!34070140
unlimited free pdf from europmc34070140    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid34070140      Molecules 2021 ; 26 (10): ä
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Prioritisation of Compounds for 3CL(pro) Inhibitor Development on SARS-CoV-2 Variants #MMPMID34070140
  • Jukic M; Skrlj B; Tomsic G; Plesko S; Podlipnik C; Bren U
  • Molecules 2021[May]; 26 (10): ä PMID34070140show ga
  • COVID-19 represents a new potentially life-threatening illness caused by severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 pathogen. In 2021, new variants of the virus with multiple key mutations have emerged, such as B.1.1.7, B.1.351, P.1 and B.1.617, and are threatening to render available vaccines or potential drugs ineffective. In this regard, we highlight 3CL(pro), the main viral protease, as a valuable therapeutic target that possesses no mutations in the described pandemically relevant variants. 3CL(pro) could therefore provide trans-variant effectiveness that is supported by structural studies and possesses readily available biological evaluation experiments. With this in mind, we performed a high throughput virtual screening experiment using CmDock and the "In-Stock" chemical library to prepare prioritisation lists of compounds for further studies. We coupled the virtual screening experiment to a machine learning-supported classification and activity regression study to bring maximal enrichment and available structural data on known 3CL(pro) inhibitors to the prepared focused libraries. All virtual screening hits are classified according to 3CL(pro) inhibitor, viral cysteine protease or remaining chemical space based on the calculated set of 208 chemical descriptors. Last but not least, we analysed if the current set of 3CL(pro) inhibitors could be used in activity prediction and observed that the field of 3CL(pro) inhibitors is drastically under-represented compared to the chemical space of viral cysteine protease inhibitors. We postulate that this methodology of 3CL(pro) inhibitor library preparation and compound prioritisation far surpass the selection of compounds from available commercial "corona focused libraries".
  • |*Coronavirus 3C Proteases/antagonists & inhibitors/chemistry[MESH]
  • |*Small Molecule Libraries[MESH]
  • |Antiviral Agents/*chemistry[MESH]
  • |Cysteine Proteinase Inhibitors/*chemistry[MESH]
  • |Humans[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box